Operative Unit of Endocrinology, A. Gemelli Foundation, Catholic University of the Sacred Heart, School of Medicine, Rome, Italy.
Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3936-3961. doi: 10.26355/eurrev_201806_15279.
Chronic Heart Failure (CHF) is associated with multi-hormonal derangement depicting a prevalence of catabolic vs. anabolic axes. Moreover, thyroid adaption is characterized by the reduced conversion of thyroxine to the active hormone triiodothyronine. On the other hand, hormones modulate synthesis and utilization of antioxidant systems. Therefore, hormonal failure can cause unbalance between reactive radical species and the defenses, resulting in oxidative stress (OS). OS is well described in CHF, but the relationship with the hormonal picture is not entirely known. In the present review, we firstly analyze the mechanisms of ROS production in the heart, discussing animal and human studies, and focusing on new discovered protective mechanisms such as sirtuins and fibroblast growth factor 21 (FGF21). The second section is dedicated to the role of main anabolic axes influencing antioxidant systems. Finally, we present some data supporting the hypothesis that OS could be the link between hormonal derangement and clinical outcome of CHF.
慢性心力衰竭(CHF)与多种激素失调有关,表现为分解代谢轴与合成代谢轴的失衡。此外,甲状腺的适应特征是甲状腺素向活性激素三碘甲状腺原氨酸的转化减少。另一方面,激素调节抗氧化系统的合成和利用。因此,激素衰竭会导致活性自由基和防御之间的失衡,导致氧化应激(OS)。OS 在 CHF 中描述得很好,但与激素状态的关系尚不完全清楚。在本综述中,我们首先分析了心脏中 ROS 产生的机制,讨论了动物和人体研究,并重点关注了新发现的保护机制,如沉默信息调节因子 2 相关酶 1(SIRT1)和成纤维细胞生长因子 21(FGF21)。第二部分专门介绍了影响抗氧化系统的主要合成代谢轴的作用。最后,我们提出了一些数据,支持 OS 可能是 CHF 中激素失调与临床结局之间联系的假说。